SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
As of January 1st, 2018 New Horizons in Translational Medicine, the official publication of the European Society for Translational Medicine (EUSTM), is no longer published by Elsevier.
The journal has been merged with its sister publication New Horizons in Clinical Case Reports and is now published by Ubiquity Press: <a href="https://www.ejmcm.com/">www.ejmcm.com
New Horizons in Translational Medicine (NHTM) is the official publication of the
<a href="http://www.eutranslationalmedicine.org/">European Society for Translational Medicine. NHTM publishes high quality manuscripts covering all aspects of translational medicine. Special consideration is given to novel findings generated in cellular and molecular biology and omics disciplines. Moreover, high quality manuscripts describing novel developments in the field of biomarkers, disease modelling, big data mining and management are considered for publication. Along with original studies, focused reviews are also welcomed. Selection of papers for peer review and potential publication is based on their scientific excellence, distinctive contribution to knowledge (including methodological development) and their importance to the field.
Manuscript types in NHTM:
Compliance with Funding Bodies and Open Access Publication in NHTM fulfils many funding body policies for Open Access. The Publisher, Elsevier, has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies, including but not limited to the Biotechnology and Biological Sciences Research Council (UK), Department of Health UK, European Molecular Biology Laboratory, Howard Hughes Medical Institute (US), Medical Research Council (UK), National Institutes of Health (US), Wellcome Trust (UK) and the World Health Organisation.
To learn more about existing agreements please visit <a href="https://www.elsevier.com/fundingbodies">.